Atlas Trials

Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients

Clinical trial NCT05301829 · UNKNOWN

Trial details

NCT number
NCT05301829
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
Nephrotic Syndrome
Start date
2022-04-01
Primary completion
2022-10-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.